Sectors
ARCT
Arcturus Therapeutics Holdings Inc.
5.90
1 x 5.92
2 x 5.94
bid
ask
-
0.09
1.50%
10:02 AM
timesize
| Ytd | -3.75% | |
| 1y | -59.39% |
5.90
day range
5.99
5.77
52 week range
24.17
| Open | 5.97 | Prev Close | 5.99 | Low | 5.90 | High | 5.99 | Mkt Cap | 170.25M |
| Vol | 59.13K | Avg Vol | 465.09K | EPS | -2.81 | P/E | -2.13 | Forward P/E | -7.41 |
| Beta | 2.37 | Short Ratio | 9.41 | Inst. Own | 90.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 7.21 | 200-d Avg | 8.49 | 1yr Est | 79.47 |
| Income Statement | |||
| Total Revenue | 2.06M | ||
| Revenues (USD) | 2.06M | ||
| Gross Profit | 2.06M | ||
| Operating Expenses | 30.99M | ||
| Research and Development Expense | 21.53M | ||
| Selling, General and Administrative Expense | 9.47M | ||
| Operating Income | -28.93M | ||
| Net Income | -26.96M | ||
| Net Income Common Stock | -26.96M | ||
| Net Income Common Stock (USD) | -26.96M | ||
| Consolidated Income | -26.96M | ||
| Earnings per Basic Share | -0.95 | ||
| Earnings per Basic Share (USD) | -0.95 | ||
| Earnings per Diluted Share | -0.95 | ||
| Earning Before Interest & Taxes (EBIT) | -26.96M | ||
| Earning Before Interest & Taxes (USD) | -26.96M | ||
| Weighted Average Shares | 28.42M | ||
| Weighted Average Shares Diluted | 28.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 211.38M | ||
| Cash and Equivalents (USD) | 211.38M | ||
| Investments | 2.03M | ||
| Investments Non-Current | 2.03M | ||
| Trade and Non-Trade Receivables | 1.34M | ||
| Current Assets | 216.88M | ||
| Property, Plant & Equipment Net | 26.50M | ||
| Total Assets | 245.41M | ||
| Total Debt | 19.68M | ||
| Current Liabilities | 34.37M | ||
| Debt Non-Current | 19.68M | ||
| Total Liabilities | 54.05M | ||
| Accumulated Retained Earnings (Deficit) | -541.55M | ||
| Shareholders Equity | 191.36M | ||
| Shareholders Equity (USD) | 191.36M | ||
| Assets Non-Current | 28.53M | ||
| Total Debt (USD) | 19.68M | ||
| Deferred Revenue | 7.61M | ||
| Liabilities Non-Current | 19.68M | ||
| Trade and Non-Trade Payables | 4.09M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 658.00K | ||
| Net Cash Flow from Financing | 16.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.39M | ||
| Capital Expenditure | 34.00K | ||
| Issuance (Purchase) of Equity Shares | 16.00K | ||
| Net Cash Flow from Investing | 34.00K | ||
| Net Cash Flow from Operations | -19.44M | ||
| Share Based Compensation | 4.33M | ||